Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study

W. J. A. Witlox*, B. L. T. Ramaekers, H. J. M. Groen, A. M. Dingemans, J. Praag, J. Belderbos, V. van der Noort, H. van Tinteren, M. A. Joore, D. K. M. De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1528-1531
Number of pages4
JournalActa Oncologica
Volume58
Issue number10
Early online date27 Jun 2019
DOIs
Publication statusPublished - 3 Oct 2019

Keywords

  • BRAIN METASTASES
  • HIGH-RISK
  • CHEMORADIOTHERAPY
  • CHEMOTHERAPY
  • TRIAL

Cite this